The paracetamol metabolite N-acetyl-4-benzoquinoneimine (NAPQI) prevents modulation of KV7 channels via G-protein coupled receptors by interference with PIP2 and Ca2+ sensitivity

IF 6.8 2区 医学 Q1 PHARMACOLOGY & PHARMACY
Thomas Losgott, Oliver Kudlacek, Jae-Won Yang, Klaus W. Schicker, Stefan Boehm, Isabella Salzer
{"title":"The paracetamol metabolite N-acetyl-4-benzoquinoneimine (NAPQI) prevents modulation of KV7 channels via G-protein coupled receptors by interference with PIP2 and Ca2+ sensitivity","authors":"Thomas Losgott,&nbsp;Oliver Kudlacek,&nbsp;Jae-Won Yang,&nbsp;Klaus W. Schicker,&nbsp;Stefan Boehm,&nbsp;Isabella Salzer","doi":"10.1111/bph.17419","DOIUrl":null,"url":null,"abstract":"<div>\n \n <section>\n \n <h3> Background and Purpose</h3>\n \n <p>Paracetamol has been found to alleviate inflammatory pain by modulating K<sub>V</sub>7 channels. Its metabolite N-acetyl-4-benzoquinoneimine (NAPQI) increases currents through these channels via a stretch of three cysteine residues in the channel S2–S3 linker. Through this effect, the excitability of neurons in the pain pathway is dampened. Inflammatory mediators, in turn, enhance the excitability of sensory neurons by inhibiting K<sub>V</sub>7 channels. Here, a specific interaction between NAPQI and the so-called inflammatory soup was investigated.</p>\n </section>\n \n <section>\n \n <h3> Experimental Approach</h3>\n \n <p>Currents through K<sub>V</sub>7 channels were measured in sensory neurons and after heterologous expression in tsA201 cells. In addition, changes in cytosolic Ca<sup>2+</sup> and in the distribution of PIP<sub>2</sub> (PI(4,5)P<sub>2</sub>) between membrane and cytosol were determined by fluorescence microscopy.</p>\n </section>\n \n <section>\n \n <h3> Key Results</h3>\n \n <p>NAPQI abolished Ca<sup>2+</sup>-mediated inhibitory effects of an ‘inflammatory soup’ containing ADP, ATP, bradykinin, histamine, 5-hydroxytryptamine, prostaglandin E<sub>2</sub>, substance P and a PAR2 agonist on K<sub>V</sub>7 channel currents in sensory neurons. Moreover, the increase of K<sub>V</sub>7.2 channel currents by quenching of cytosolic Ca<sup>2+</sup> as well as the current decrease by depletion of membrane PIP<sub>2</sub> was impaired by NAPQI. These effects were lost in mutant channels lacking the three cysteines in the S2–S3 linker.</p>\n </section>\n \n <section>\n \n <h3> Conclusion and Implication</h3>\n \n <p>NAPQI targets the three-cysteine motif in the S2–S3 linker of K<sub>V</sub>7.2 channels to counteract the signalling cascades employed by inflammatory mediators that inhibit these channels. In sensory neurons, this abolishes the closure of K<sub>V</sub>7 channels by the inflammatory soup. This mechanism is likely involved in the alleviation of inflammatory pain by paracetamol.</p>\n </section>\n </div>","PeriodicalId":9262,"journal":{"name":"British Journal of Pharmacology","volume":"182 6","pages":"1341-1357"},"PeriodicalIF":6.8000,"publicationDate":"2024-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/bph.17419","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/bph.17419","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and Purpose

Paracetamol has been found to alleviate inflammatory pain by modulating KV7 channels. Its metabolite N-acetyl-4-benzoquinoneimine (NAPQI) increases currents through these channels via a stretch of three cysteine residues in the channel S2–S3 linker. Through this effect, the excitability of neurons in the pain pathway is dampened. Inflammatory mediators, in turn, enhance the excitability of sensory neurons by inhibiting KV7 channels. Here, a specific interaction between NAPQI and the so-called inflammatory soup was investigated.

Experimental Approach

Currents through KV7 channels were measured in sensory neurons and after heterologous expression in tsA201 cells. In addition, changes in cytosolic Ca2+ and in the distribution of PIP2 (PI(4,5)P2) between membrane and cytosol were determined by fluorescence microscopy.

Key Results

NAPQI abolished Ca2+-mediated inhibitory effects of an ‘inflammatory soup’ containing ADP, ATP, bradykinin, histamine, 5-hydroxytryptamine, prostaglandin E2, substance P and a PAR2 agonist on KV7 channel currents in sensory neurons. Moreover, the increase of KV7.2 channel currents by quenching of cytosolic Ca2+ as well as the current decrease by depletion of membrane PIP2 was impaired by NAPQI. These effects were lost in mutant channels lacking the three cysteines in the S2–S3 linker.

Conclusion and Implication

NAPQI targets the three-cysteine motif in the S2–S3 linker of KV7.2 channels to counteract the signalling cascades employed by inflammatory mediators that inhibit these channels. In sensory neurons, this abolishes the closure of KV7 channels by the inflammatory soup. This mechanism is likely involved in the alleviation of inflammatory pain by paracetamol.

Abstract Image

对乙酰氨基酚代谢物n -乙酰基-4-苯醌亚胺(NAPQI)通过干扰PIP2和Ca2+敏感性,通过g蛋白偶联受体阻止KV7通道的调节。
背景与目的:研究发现扑热息痛通过调节KV7通道减轻炎症性疼痛。它的代谢物n -乙酰基-4-苯醌亚胺(NAPQI)通过通道S2-S3连接体中的三个半胱氨酸残基增加通过这些通道的电流。通过这种效应,疼痛通路中神经元的兴奋性受到抑制。反过来,炎症介质通过抑制KV7通道增强感觉神经元的兴奋性。在这里,研究了NAPQI与所谓的炎症汤之间的特定相互作用。实验方法:测量感觉神经元和tsA201细胞异种表达后的KV7通道电流。荧光显微镜观察胞质内Ca2+的变化以及膜与胞质间PIP2 (PI(4,5)P2)的分布。关键结果:NAPQI消除了含有ADP、ATP、缓激肽、组胺、5-羟色胺、前列腺素E2、P物质和PAR2激动剂的“炎症汤”对感觉神经元KV7通道电流的Ca2+介导的抑制作用。此外,NAPQI还破坏了胞质Ca2+猝灭导致的KV7.2通道电流的增加以及细胞膜PIP2耗竭导致的电流减少。在S2-S3连接体中缺乏三种半胱氨酸的突变通道中,这些效应消失了。结论和意义:NAPQI靶向KV7.2通道S2-S3连接中的3 -半胱氨酸基序,以抵消炎症介质抑制这些通道所采用的信号级联反应。在感觉神经元中,这消除了炎症汤对KV7通道的关闭。这一机制可能与扑热息痛减轻炎症性疼痛有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
15.40
自引率
12.30%
发文量
270
审稿时长
2.0 months
期刊介绍: The British Journal of Pharmacology (BJP) is a biomedical science journal offering comprehensive international coverage of experimental and translational pharmacology. It publishes original research, authoritative reviews, mini reviews, systematic reviews, meta-analyses, databases, letters to the Editor, and commentaries. Review articles, databases, systematic reviews, and meta-analyses are typically commissioned, but unsolicited contributions are also considered, either as standalone papers or part of themed issues. In addition to basic science research, BJP features translational pharmacology research, including proof-of-concept and early mechanistic studies in humans. While it generally does not publish first-in-man phase I studies or phase IIb, III, or IV studies, exceptions may be made under certain circumstances, particularly if results are combined with preclinical studies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信